Palisade Bio (PALI) Profit After Tax (QoQ) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Palisade Bio | 439.25 Mn | 309.68 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7.88% |
| Dec 31, 2025 | -210.29% |
| Sep 30, 2025 | -3.02% |
| Jun 30, 2025 | -24.84% |
| Mar 31, 2025 | 33.31% |
| Dec 31, 2024 | 4.10% |
| Sep 30, 2024 | 14.53% |
| Jun 30, 2024 | -15.68% |
| Mar 31, 2024 | -18.71% |
| Dec 31, 2023 | 17.38% |
| Sep 30, 2023 | -5.98% |
| Jun 30, 2023 | -45.00% |
| Mar 31, 2023 | 37.10% |
| Dec 31, 2022 | 6.79% |
| Sep 30, 2022 | -70.26% |
| Jun 30, 2022 | 44.26% |
| Mar 31, 2022 | -491.89% |
| Dec 31, 2021 | -86.73% |
| Sep 30, 2021 | 125.47% |
| Jun 30, 2021 | -687.74% |
| Mar 31, 2021 | 5.04% |
| Dec 31, 2020 | -130.28% |
| Sep 30, 2020 | 0.43% |
| Jun 30, 2020 | 22.36% |
| Mar 31, 2020 | -17.00% |
| Dec 31, 2019 | -15.57% |
| Sep 30, 2019 | -22.70% |
| Jun 30, 2019 | 53.86% |
| Mar 31, 2019 | -872.15% |
| Dec 31, 2018 | 82.50% |
| Sep 30, 2018 | -191.89% |
| Jun 30, 2018 | 70.79% |
| Mar 31, 2018 | 35.25% |
| Dec 31, 2017 | -2,378.46% |
| Sep 30, 2017 | 97.12% |
| Jun 30, 2017 | 38.56% |
| Mar 31, 2017 | -40.24% |
| Dec 31, 2016 | -3.37% |
| Sep 30, 2016 | -35.50% |
| Jun 30, 2016 | 41.68% |
| Mar 31, 2016 | -38.63% |
| Dec 31, 2015 | 15.48% |
| Sep 30, 2015 | -3.48% |
| Jun 30, 2015 | -7.81% |
| Mar 31, 2015 | 8.18% |
| Dec 31, 2014 | -23.52% |
| Sep 30, 2014 | 34.01% |
| Jun 30, 2014 | -14.06% |
| Mar 31, 2014 | -79.19% |
| Dec 31, 2013 | 50.60% |
| Sep 30, 2013 | -6.96% |
| Jun 30, 2013 | -74.14% |
| Mar 31, 2013 | -32.23% |
| Dec 31, 2012 | -5.34% |
| Sep 30, 2012 | -8.46% |
| Jun 30, 2012 | 3.11% |
| Mar 31, 2012 | 4.05% |
| Dec 31, 2011 | 20.40% |
| Sep 30, 2011 | 11.98% |
| Jun 30, 2011 | -17.63% |
| Mar 31, 2011 | -13.26% |
| Dec 31, 2010 | 30.32% |
| Sep 30, 2010 | 20.62% |